首页> 外文期刊>The Canadian journal of cardiology >MicroRNA deregulation in right ventricular outflow tract myocardium in nonsyndromic tetralogy of fallot
【24h】

MicroRNA deregulation in right ventricular outflow tract myocardium in nonsyndromic tetralogy of fallot

机译:法洛非综合征四联症右室流出道心肌中的MicroRNA失调

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Tetralogy of Fallot (TOF) is 1 of the most common heart defects in children, and the underlying mechanisms remain largely elusive. MicroRNAs (miRNAs) are a class of regulators of gene expression and are increasingly recognized for their roles in heart development. Methods: To identify miRNAs abnormally expressed in TOF, microarrays were used to analyze the miRNA expression profiles of 5 samples of myectomy tissues from right ventricular outflow tract (RVOT) obstruction of infants with nonsyndromic TOF and 3 age-matched normal RVOT tissues. Results: In total, 41 candidate miRNAs were identified. To further validate the microarray results, the 41 miRNAs were detected using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) in a larger independent population of tissue samples, including 21 from patients with TOF and 6 from normal controls; it was found that 18 miRNAs were expressed at significantly different levels. Bioinformatic analysis revealed that these miRNAs targeted a network of genes involved in heart development and human congenital heart diseases. Further invitro studies indicated that upregulation of miR-424/424* promoted proliferation and inhibited migration of primary embryonic mouse cardiomyocytes, whereas miR-222 promoted cardiomyocyte proliferation and reduced the cardiomyogenic differentiation of P19 cells. The 3'UTR (3' untranslated region) luciferase assay revealed that miR-424/424* suppressed the expression of HAS2 and NF1, and their mRNAs were underexpressed in the RVOT myocardial tissues of TOF. Conclusions: Eighteen miRNAs were identified as being deregulated in RVOT myocardial tissues from infants with nonsyndromic TOF, and invitro experiments indicated that miR-424/424* and miR-222 are involved in cardiomyocyte proliferation and migration and the cardiomyogenic differentiation of P19 cells.
机译:背景:法洛四联症(TOF)是儿童中最常见的心脏缺陷之一,其潜在机制仍然难以捉摸。微小RNA(miRNA)是一类基因表达的调节剂,其在心脏发育中的作用日益受到人们的认可。方法:为了鉴定TOF中异常表达的miRNA,使用微阵列分析了5例非综合征性TOF婴儿右室流出道梗阻和3例年龄相匹配的正常RVOT肌切除组织样本中miRNA的表达谱。结果:总共鉴定出41种候选miRNA。为了进一步验证微阵列结果,使用定量逆转录酶聚合酶链反应(qRT-PCR)在较大的独立组织样本中检测了41个miRNA,其中包括21例来自TOF患者和6例来自正常对照。发现18个miRNA以明显不同的水平表达。生物信息学分析表明,这些miRNA靶向于涉及心脏发育和人类先天性心脏病的基因网络。进一步的体外研究表明,miR-424 / 424 *的上调促进了原代胚胎小鼠心肌细胞的增殖并抑制了其迁移,而miR-222促进了心肌细胞的增殖并降低了P19细胞的心肌分化。 3'UTR(3'非翻译区)荧光素酶测定显示,miR-424 / 424 *抑制了HAS2和NF1的表达,并且它们的mRNA在TOF的RVOT心肌组织中表达不足。结论:在未患有TOF的婴儿的RVOT心肌组织中鉴定出18个miRNA失控,体外实验表明miR-424 / 424 *和miR-222参与了心肌细胞的增殖和迁移以及P19细胞的心肌分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号